Wave Life Sciences Ltd (WVE) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.35 (-2.03%), Market cap $1.36B, 52-week low–high $5.94 ~ $21.31.
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-008, a GalNAc-conjugated RNA editing oligonucleotide for the t
Financial statements, price targets, institutional (13F) holdings and related news for Wave Life Sciences Ltd are updated in real time on BlackAll Trade.
Wave Life Sciences Ltd trades at $4.35 (-2.03%). Real-time quotes and charts are available on BlackAll Trade.
Wave Life Sciences Ltd has a market cap of about $1.36B.
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The co